Michael Howell - 18 Jun 2024 Form 4 Insider Report for Zura Bio Ltd (ZURA)

Role
Chief Scientific Officer and Head of Translational Science
Signature
/s/ Michael Howell
Issuer symbol
ZURA
Transactions as of
18 Jun 2024
Net transactions value
$0
Form type
4
Filing time
21 Jun 2024, 18:11:56 UTC
Previous filing
08 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZURA Employee Share Option (Right to Buy) Award $0 +295,000 $0.000000 295,000 18 Jun 2024 Class A Ordinary Shares 295,000 $3.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One fourth (1/4th) of the shares subject to the option award shall vest on June 18, 2025, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

Remarks:

Chief Scientific Officer and Head of Translational Science